Solving the Tacit Knowledge Gap in Pharmaceutical Tech Transfer
Beyond Documentation: Solving the Tacit Knowledge Gap in Pharmaceutical Tech Transfer: Why Your Documentation Is Not Enough and How to Institutionalize Expert Know-How.
In the high-stakes world of pharmaceutical manufacturing, technology transfer is often viewed through the lens of rigid documentation, master batch records, analytical methods, and validation protocols. Yet, despite having exhaustive paper trails, many projects suffer from unexpected delays, process variability, and quality deviations. (1).
The culprit is rarely a flaw in the paperwork itself. It is the silent, pervasive gap in tacit knowledge, the “unwritten” experience-based know-how that lives exclusively in the minds of your technical experts.
The Hidden Risk of “Paper-Only” Transfers
Tacit knowledge is inherently personal. It includes the “troubleshooting intuition” of a veteran operator who knows exactly how a piece of equipment sounds when it’s running optimally. It also encompasses the historical context behind a specific process deviation that isn’t recorded in the official archives. (2).
When technology transfer relies solely on codified documentation, you are essentially asking the receiving team to learn an entire craft from a textbook. This perspective overlooks the reality that in complex GMP environments, expert performance often arises from “indwelling,” meaning the ability to intuitively perceive and respond to subtle process cues that cannot be fully captured in a standard operating procedure (SOP). Relying on documents alone is a high-risk strategy that often leads to increased training times, lower yields, and recurring quality issues during scale-up. However, if the Receiving Unit (RU) identifies particular problems with the process during the transfer, it should communicate these issues back to the Sending Unit (SU) to ensure ongoing knowledge management (3).
The Human-to-Human Advantage
To truly de-risk your technology transfer, you must move beyond the “document-handover” mindset. The highest-leverage approach integrates human-to-human transfer mechanisms, which act as the bridge between explicit documentation and operational mastery.
1- Strategic Secondments and Shadowing
Placing key staff from the sending unit directly into the receiving unit or vice versa is the gold standard for transferring nuanced process knowledge. Shadowing allows receiving team members to observe how critical process parameters (CPPs) are managed in real-time, providing an opportunity to ask the “why” behind the “how.” It turns passive learning into an active, observational experience.
2- Communities of Practice (CoPs)
CoPs represent a powerful, sustainable way to manage knowledge beyond the project lifecycle. By bringing together subject matter experts from cross-functional teams, these communities provide a safe space for practitioners to share troubleshooting tips, discuss deviations, and refine methods. Unlike formal training, which is often transactional, CoPs foster a culture of collective intelligence, ensuring that lessons learned in one department or facility are disseminated throughout the organization.
3- Mentorship and Structured Reflection
Formalizing mentorship roles ensures that tacit knowledge is not lost when senior staff retire or rotate. Incorporating structured reflection sessions after key transfer milestones, where teams explicitly discuss what they learned beyond what was written in the reports, creates a cycle of continuous improvement that strengthens the organization’s overall competency.
Bridging the Gap
At the intersection of regulatory compliance and operational excellence, successful technology transfer is not just about meeting the requirements of a GMP audit. It is about building a robust, knowledge-enabled workforce that can navigate complexity with confidence.
Documentation is necessary for compliance, but a human-to-human connection is essential for performance. By operationalizing these human-centric strategies, you reduce your reliance on trial and error and shorten the time-to-market for critical healthcare products.
References
1- Upperton; Navigating Technology Transfer in Pharmaceutical Manufacturing: Best Practices, https://upperton.com/navigating-technology-transfer-in-pharmaceutical-manufacturing-best-practices/
2- Dr. Lars Lueersen. Knowledge Management, GMP Journal; 15.05.2019; https://www.gmp-journal.com/current-articles/details/knowledge-management.html#:~:text=3%2C4,and%20experiences%20of%20the%20individual.
3- WHO Guidelines on Technology Transfer in Pharmaceutical Manufacturing; TRS 1044, Annex 4
4- Navigating the Pitfalls of MSAT for Successful Technology Transfer | Mivado GlobalPerformance